Shenzhen Hospital of Southern Medical University

date:2025-09-11

Shenzhen Hospital of Southern Medical University

Shenzhen Hospital of Southern Medical University: A High-Level Medical Hub in the Guangdong-Hong Kong-Macao Greater Bay Area, Setting a Benchmark for the Integration of Medical Care, Education, Research, and Industry

I. Hospital Overview

Shenzhen Hospital of Southern Medical University (formerly Shenzhen Hengsheng Hospital) is a directly affiliated hospital of Southern Medical University and a designated high-level hospital construction unit in Guangdong Province. Jointly established by the Shenzhen Municipal Government and Southern Medical University, it commenced operations in 2010 and completed its full relocation to the new campus (1333 Xinhu Road, Bao'an District) in 2021. Spanning 230,000 square meters with a planned capacity of 2,500 beds (1,500 beds operational in Phase I), the hospital handles over 3 million outpatient visits and performs more than 50,000 surgeries annually. As a large-scale modern Grade A tertiary general hospital integrating medical care, teaching, research, prevention, and health preservation, it serves as the regional medical center for western Shenzhen.

Leveraging the disciplinary strengths of Southern Medical University (a nationally top-100 medical institution), the hospital has established a “specialized excellence, comprehensive development” model. It boasts National Key Clinical Specialties (Organ Transplantation), Guangdong Provincial High-Level Key Clinical Specialties (Cardiovascular Medicine, Neurosurgery), and Shenzhen Municipal Key Medical Disciplines (Cancer Center, Critical Care Medicine). It also serves as the “Shenzhen Clinical Medical College of Southern Medical University” and the “Guangdong Provincial Postdoctoral Innovation Practice Base,” undertaking undergraduate and graduate teaching with over 500 medical students trained annually. With annual research funding exceeding 200 million yuan, it stands as a leading integrated medical hub for “medical care, education, research, and industry” in western Shenzhen.

II. Technological Advantages: Innovation-Driven Regional Healthcare Advancement

Guided by the core principles of precision medicine, smart healthcare, and translational medicine, the hospital focuses on treating complex and critical illnesses while advancing cutting-edge technologies. It has established significant strengths in the following areas:

• Organ Transplantation Technology: As one of the first hospitals in South China accredited for liver, kidney, heart, and lung transplants, it performs over 300 transplant surgeries annually (2024 data). The one-year survival rate for liver transplant recipients reaches 95% (exceeding the national average), with pediatric liver transplantation technology filling a gap in Shenzhen.

• Cardiovascular Interventional Therapy: Equipped with hybrid operating rooms, the hospital performs complex coronary interventions (e.g., chronic total occlusion, left main bifurcation lesions), structural heart interventions (transcatheter aortic valve implantation [TAVI], mitral valve clipping), and radiofrequency ablation for arrhythmias. Annual procedure volume exceeds 5,000 cases. D-to-B time (door-to-balloon time) for acute myocardial infarction patients has been reduced to under 60 minutes (international standard: 90 minutes).

• Minimally Invasive Neurosurgery: Utilizing “neuro-navigation + fluorescence imaging” systems and intraoperative electrophysiological monitoring, we perform high-complexity procedures including brainstem tumor resection, acoustic neuroma removal, and aneurysm clipping. Our “keyhole approach” minimally invasive technique reduces disability rates by 40% in intracranial hemorrhage patients.

• Precision Oncology: Established the Tumor Gene Testing Center and Immunotherapy Laboratory, implementing multidisciplinary tumor consultations (MDT), targeted therapies, and CAR-T cell treatments. Tailored personalized plans for common cancers like lung and breast cancer, increasing the 5-year survival rate for advanced-stage patients by 25% compared to traditional treatments.

• Smart Healthcare Services: Among the nation's first institutions to pass the “Level 5 Electronic Medical Record Evaluation,” we launched “5G Remote Surgical Guidance,” “AI-Assisted Diagnosis (for lung nodules/retinal lesions),” and an “Intelligent Triage System.” Average patient wait times have been reduced to under 30 minutes, with 100% online access to test results.

III. Leading Specialties: Powerhouse Specialty Clusters Addressing Lifecycle Health Needs

The hospital has established a “1+10+N” specialty system (1 National Key Specialty + 10 Provincial/Municipal Key Specialties + N Distinctive Subspecialties). Core leading specialties include:

• Organ Transplant Center: A National Key Clinical Specialty covering liver, kidney, heart, and lung transplants. Equipped with a domestically advanced Organ Procurement Organization (OPO), it maintains organ sharing and technical collaborations with the First Affiliated Hospital of Sun Yat-sen University and the University of Pittsburgh Medical Center (UPMC).

• Cardiovascular Medicine: A Guangdong Provincial High-Level Clinical Key Specialty excelling in comprehensive management of coronary heart disease, hypertension, arrhythmias, and heart failure. It operates three specialized centers: the Chest Pain Center, Atrial Fibrillation Center, and Heart Failure Center, performing over 2,000 PCI (Percutaneous Coronary Intervention) procedures annually.

• Neurosurgery: A key medical discipline in Shenzhen, focusing on cerebrovascular diseases (intracerebral hemorrhage, cerebral infarction), brain tumors, and functional neurosurgery (Parkinson's DBS surgery). Equipped with a “mobile ICU ambulance” to enable “admission upon boarding” for stroke patients during the golden treatment window.

• Cancer Center: Leading institution of Shenzhen Cancer Prevention and Treatment Alliance, offering multimodal therapy combining surgery, radiotherapy, chemotherapy, and immunotherapy. Features Shenzhen's first spiral tomotherapy (TOMO) and CyberKnife systems, achieving an 82% effective rate in comprehensive cancer treatment.

• Critical Care Medicine (ICU): Designated as Shenzhen Critical Care Center, equipped with advanced technologies including ECMO (Extracorporeal Membrane Oxygenation) and Continuous Renal Replacement Therapy (CRRT). Treats over 3,000 critically ill patients annually, achieving an 85% success rate in rescuing patients with sepsis, ARDS, and other life-threatening conditions.

IV. Departmental Structure: Comprehensive Coverage for Diverse Healthcare Needs

The hospital features comprehensive departments covering prevention, diagnosis, treatment, and rehabilitation. Core departments include:

• Clinical Departments: Internal Medicine (Cardiovascular, Neurology, Respiratory, Gastroenterology, Endocrinology, etc.), Surgery (General Surgery, Orthopedics, Neurosurgery, Cardiothoracic Surgery, Urology, etc.), Obstetrics and Gynecology (Obstetrics, Gynecology, Reproductive Medicine), Pediatrics (Neonatology, Child Health), Emergency Medicine, Critical Care Medicine, Dermatology, Ophthalmology, Otolaryngology, Dentistry, Rehabilitation Medicine, Traditional Chinese Medicine, Anesthesiology.

• Medical Technology Departments: Medical Imaging (3.0T MRI, 256-slice CT, PET-CT), Laboratory Medicine (Precision Genetic Testing), Pathology (Digital Pathology Diagnosis), Ultrasound Medicine (Interventional Ultrasound), Nuclear Medicine (SPECT/CT), Operating Rooms (Multifunctional Operating Rooms, Robotic Surgery Suites), Central Sterile Supply Department.

V. Medical Equipment: World-Class Technology for Precision Diagnosis and Treatment

The hospital is equipped with globally leading medical devices, ensuring technological alignment with international standards:

• Surgical Equipment: Da Vinci Xi Surgical Robot (urology, general surgery, gynecology), Philips Azurion 7 M20 Angiography System (cardiovascular intervention), Zeiss Kinevo 900 Microscope (neurosurgery).

• Diagnostic Equipment: Siemens Prisma 3.0T MRI (neuroimaging), GE Revolution 256-slice CT (cardiovascular/cerebrovascular imaging), Varian Halcyon linear accelerator (cancer radiotherapy), Roche Cobas 8000 fully automated biochemical analyzer (precision testing).

• Therapeutic Equipment: Medtronic Evolution mechanical thrombectomy system (lower extremity arterial occlusion), Boston Scientific Watchman left atrial appendage occluder (atrial fibrillation stroke prevention), Olympus 290 electronic gastroscope/duodenoscope (early cancer screening).

VI. International Patient Services: Comprehensive Cross-Border Healthcare for a Global Medical Experience

As a designated “International Medical Pilot Hospital” in Shenzhen, we provide foreign nationals with seamless one-stop services:

• Multilingual Support: Professional interpreters fluent in 10 languages, including English, Japanese, Korean, and Arabic, accompany patients throughout outpatient visits, examinations, and hospital stays. Critical medical documents are provided in bilingual Chinese-English versions.

• Insurance & Payment: Direct billing with international health insurers (MSH, Cigna, BUPA, etc.), foreign currency settlement via Visa, MasterCard, UnionPay, and bilingual itemized billing.

• Priority Access: Dedicated International Medical Department (separate ward area) with expedited appointments, tests, and surgeries. Routine tests completed within 24 hours, specialist consultations scheduled within 48 hours, surgeries arranged within 72 hours (Immediate treatment for critical emergencies).

• Support Services: Airport/station transfers (private vehicles/helicopters), hotel reservations (partnered premium hotels at negotiated rates), visa extension assistance, and customized Chinese/Western dining options including religious dietary requirements (halal, vegetarian, etc.).

VII. Medical Rankings: Regional Leader, Nationally Recognized

• Domestic Rankings: In Fudan University's 2023 China Hospital Reputation Ranking for South China Specialties, Organ Transplantation ranked 3rd in South China, while Cardiovascular Medicine and Neurosurgery both entered the South China Top 10. In Alibee's 2024 China Hospital Competitiveness Ranking for Prefecture-Level City Hospitals, the institution ranked 32nd overall (4th in Shenzhen).

• International Influence: Maintains long-term collaborations with Johns Hopkins Hospital (USA), Mayo Clinic (USA), and the University Hospital of Munich (Germany), conducting regular international telemedicine consultations, expert exchanges, and joint surgeries. Awarded the title of “Guangdong Provincial Demonstration Unit for Foreign-Related Medical Services” in 2024.

VIII. International Patient Testimonials: “A Model of Professional and Caring Global Healthcare”

• Emily (45, breast cancer, USA): “From overseas telemedicine consultations to surgery in Shenzhen, the medical team crafted a targeted treatment plan based on precise genetic testing. My recovery far exceeded expectations, and the nurses even taught me to say ‘thank you’ in Chinese—truly warm and caring!”

• Japanese Patient Yuki (68, Heart Valve Disease): “The Da Vinci robotic surgery completed my aortic valve replacement in just 2 hours. I was up and walking the day after surgery. The International Medical Department's interpreter was patient throughout, eliminating any communication concerns.”

• Ahmed (32, head injury, Arab patient): “ICU staff stayed by my bedside 24/7. I could call for help anytime, even late at night. Upon discharge, they gave me a rehabilitation training manual (Arabic edition)—so thoughtful!”

IX. Contact Information, Address & Transportation Routes

• Hospital Address: 1333 Xinhu Road, Bao'an District, Shenzhen (near Bao'an Central District).

• Consultation Hotline: 0755-23322222 (Main Switchboard); 0755-23322666 (International Patient Service Line).

• Transportation Routes:

• Subway: Exit E from Xinan Station (Line 1), then walk approximately 1 km (15 minutes); Exit B from Bao'an Center Station (Line 5), then transfer to bus M350/M470 for direct access.

• Bus: Direct access via “Shenzhen Hospital of Southern Medical University” stop (M200, M379, M470, M553); “Xinhu Road Intersection Station” (Routes 338, 610, 798) - 5-minute walk.

• Driving: The hospital features an underground parking garage (Fees: ¥10 for the first hour, ¥3 per hour thereafter) with over 2,000 spaces. Arrival before 8:00 AM is recommended during peak hours.

Conclusion: Guided by its motto “Compassionate Care, Innovative Excellence,” Shenzhen Hospital of Southern Medical University leverages the academic heritage of Southern Medical University and Shenzhen's innovative vitality to continuously enhance its capabilities in treating complex and critical illnesses while elevating international healthcare standards. For both residents and international patients, it stands as a trusted “lifetime health guardian.”

Document dated 2025-09-15 22:00 Modify